Deutsche Bank’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $182K | Hold |
|
|||||
|
2024
Q2 | $273K | Hold |
|
|||||
|
2024
Q1 | $256K | Hold |
|
|||||
|
2023
Q4 | $255K | Buy |
|
|||||
|
2023
Q3 | $89.9K | Sell |
|
|||||
|
2023
Q2 | $1.06M | Buy |
|
|||||
|
2023
Q1 | $190K | Buy |
|
|||||
|
2022
Q4 | $140K | Buy |
|
|||||
|
2022
Q3 | $123K | Sell |
|
|||||
|
2022
Q2 | $239K | Sell |
|
|||||
|
2022
Q1 | $328K | Sell |
|
|||||
|
2021
Q4 | $375K | Buy |
|
|||||
|
2021
Q3 | $387K | Sell |
|
|||||
|
2021
Q2 | $412K | Buy |
|
|||||
|
2021
Q1 | $370K | Sell |
|
|||||
|
2020
Q4 | $442K | Buy |
|
|||||
|
2020
Q3 | $347K | Sell |
|
|||||
|
2020
Q2 | $394K | Sell |
|
|||||
|
2020
Q1 | $492K | Sell |
|
|||||
|
2019
Q4 | $1.08M | Buy |
|
|||||
|
2019
Q3 | $945K | Buy |
|
|||||
|
2019
Q2 | $845K | Buy |
|
|||||
|
2019
Q1 | $624K | Sell |
|
|||||
|
2018
Q4 | $602K | Sell |
|
|||||
|
2018
Q3 | $4.93M | Buy |
|
|||||
|
2018
Q2 | $2.99M | Sell |
|
|||||
|
2018
Q1 | $3.6M | Buy |
|
|||||
|
2017
Q4 | $1.11M | Sell |
|
|||||
|
2017
Q3 | $6.55M | Buy |
|
|||||
|
2017
Q2 | $6.71M | Buy |
|
|||||
|
2017
Q1 | $1.74M | Sell |
|
|||||
|
2016
Q4 | $1.98M | Sell |
|
|||||
|
2016
Q3 | $5.42M | Buy |
|
|||||
|
2016
Q2 | $2.62M | Buy |
|
|||||
|
2016
Q1 | $936K | Sell |
|
|||||
|
2015
Q4 | $2.36M | Sell |
|
|||||
|
2015
Q3 | $3.15M | Buy |
|
|||||
|
2015
Q2 | $1.66M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $18K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $142K | Buy |
|
|||||
|
2014
Q1 | $9K | Buy |
|